Novel missense mutations in the tyrosine kinase domain of the platelet-derived growth factor receptor α (PDGFRA) gene in childhood acute myeloid leukemia with t(8;21) (q22;q22) or inv(16) (p13q22) [10]

Leukemia

Volumn 19, Issue 3, 2005, Pages 476-477

  Hiwatari, M ^a   Taki, T ^b   Tsuchida, M ^c   Hanada, R ^d   Hongo, T ^e   Sako, M ^f   Hayashi, Y ^g  

^a UNIVERSITY OF TOKYO   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c Ibaraki Children's Hospital   (Japan)

^d SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

^e HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f OSAKA CITY GENERAL HOSPITAL   (Japan)

^g Gumna Children S Medical Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORE BINDING FACTOR; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; CHILDHOOD LEUKEMIA; CHROMOSOME 21Q; CHROMOSOME 8Q; CHROMOSOME INVERSION; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; KARYOTYPE; LETTER; LEUKEMIA CELL LINE; LEUKEMOGENESIS; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; AMINO ACID SEQUENCE; CHILD; CHROMOSOME 16; CHROMOSOME 21; CHROMOSOME 8; GENE EXPRESSION REGULATION; GENETICS; MOLECULAR GENETICS;

AMINO ACID SEQUENCE; CHILD; CHROMOSOMES, HUMAN, PAIR 16; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INVERSION, CHROMOSOME; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PROTEIN-TYROSINE KINASES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA;

EID: 15044352509     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403638     Document Type: Letter

References (8)

1. Blume-Jensen P, Hunter T. Oncogenic kinase signalling. Nature 2001; 411: 355-365.
2. Scheijen B, Griffin JD. Tyrosine kinase oncogenes in normal hematopoiesis and hematological disease. Oncogene 2002; 21: 3314-3333.
3. Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen CJ, Joseph N et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science 2003; 299: 708-710.
4. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998; 279: 577-580.
5. Beghini A, Peterlongo P, Ripamonti CB, Larizza L, Cairoli R, Morra E et al. C-kit mutations in core binding factor leukemias. Blood 2000; 95: 726-727.
6. Nagata H, Worobec AS, Oh CK, Chowdhury BA, Tannenbaum S, Suzuki Y et al. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci USA 1995; 92: 10560-10564.
7. Yamamoto Y, Kiyoi H, Nakano Y, Suzuki R, Kodera Y, Miyawaki S et al. Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies. Blood 2001; 97: 2434-2439.
8. Spiekermann K, Bagrintseva K, Schoch C, Haferlach T, Hiddemann W, Schnittger S. A new and recurrent activating length mutation in exon 20 of the FLT3 gene in acute myeloid leukemia. Blood 2002; 100: 3423-3425.